Condition
Primary Biliary Cirrhosis clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Primary Biliary Cirrhosis clinical trials that are recruiting, at sites in 4 countries (most in United States (2), South Korea (1), China (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Primary Biliary Cirrhosis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Identifying liver disease-specific gut microbiomes | — | Daejeon, Jung-gu | Recruiting | Jul 25, 2024 |
| Biobank for cholestatic liver diseases | — | Rochester, Minnesota | Recruiting | Feb 26, 2018 |
| Assessing treatment response in patients with primary biliary cholangitis | — | Aarhus C, Central Jutland | Recruiting | Oct 13, 2016 |
| Fenofibrate added to UDCA for people with primary biliary cirrhosis not fully responding to UDCA | Phase 3 | Xi'an, Shaanxi | Recruiting | Jul 6, 2016 |
| Registry for patients with rare diseases | — | Sioux Falls, South Dakota | Recruiting | Feb 15, 2013 |
All recruiting trials (5)
-
Identifying liver disease-specific gut microbiomes
This study is trying to find out if certain gut bacteria are linked to chronic liver diseases in adults, including autoimmune hepatitis and primary biliary cholangitis, by analyzing blood and stool samples from patients and their household members.
-
Biobank for cholestatic liver diseases
This study is collecting samples and health information from people with cholestatic liver diseases to see if it can help us better understand these conditions and improve how we detect and predict them.
-
Assessing treatment response in patients with primary biliary cholangitis
This study is testing if certain blood markers can help predict how well a common treatment works for people newly diagnosed with primary biliary cholangitis.
-
Fenofibrate added to UDCA for people with primary biliary cirrhosis not fully responding to UDCA
This trial tests adding fenofibrate to UDCA for adults with primary biliary cirrhosis who did not fully respond to UDCA alone.
-
Registry for patients with rare diseases
This study is creating a central registry for people with rare diseases to help connect them with researchers and improve treatments.
Related topics
Quick answers
How many Primary Biliary Cirrhosis clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), South Korea (1 trial), China (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.